Skip to main content
. 2018 Feb 21;8(1):60–71. doi: 10.1159/000487079

Table 2.

Estimate of the population attributable risk and number of attributable cases in 2010 for AD and VaD

Risk factor Prevalencea, % ADa
VaD
Total number (in thousands) of attributable cases in 2010 for AD and VaD
PAR, % (95% CI) number (in thousands) of attributable cases in 2010 (95% CI) PARb, % (95%CI) number (in thousands) of attributable cases in 2010c (95% CI)
Diabetes mellitus 6.9 3.1 222 8.1 187 409
(1.4–5.0) (98–364) (6.1–10.3) (141–237)
Midlife hypertension 12.0 6.8 492 6.6 153 645
(1.9–13.0) (136–934) (2.3–11.8) (54–271)
Midlife obesity 7.2 4.1 299 2.3 54 353
(2.4–6.2) (172–448) (0.1–5.1) (3–118)
Physical inactivity 31.0 20.3% 1,461 15.9 367 1,828
(5.6–35.6) (401–2564) (2.7–30.0) (63–691)
Depression 18.5 10.7 774 26.2 605 1,379
(7.2–14.5) (520–1049) (13.9–39.7) (320–916)
Smoking 26.6 13.6 978 6.5 149 1,127
(3.8–24.2) (277–1,745) (1.3–11.7) (30–271)
Low educational attainment 26.6 13.6 978 31.8 733 1,711
(8.5–18.6) (614–1,342) (24.0–39.5) (555–910)
Combined 54.0 3,891 66.8 1,541 5,432
(27.2–73.7) (1,959–5,311) (42.5–83.0) (980–1,916)
Adjusted combined 31.4 3,033 37.8 873 3,906
(15.3–46.0) (1,472–4,332) (21.2–52.5) (488–1,211)

AD, Alzheimer disease; VaD, vascular dementia; PAR, population attributable risk.

a

Estimates from Norton et al. [3].

b

Estimated using the prevalence from Norton et al. [3] and risk ratio reported in Table 1.

c

Estimated multiplying PAR per number of prevalent cases of VaD in Europe (= 15.8 from Lobo et al. [2]; number of total cases of dementia from Brookmeyer et al. [9]).